The heart in sickle cell disease

Acta Cardiologica

Volumn 60, Issue 6, 2005, Pages 589-598

  Tsironi, Maria ^a,b   Aessopos, Athanasios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Cardiac function; Haemolysis; Myocardial infarction; Pulmonary hypertension; Sickle cell disease (SCD)

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; CYTOKINE; HEMOGLOBIN; HEMOGLOBIN C; HEMOGLOBIN S; HYDROXYUREA; IRON; MONOCLONAL ANTIBODY; NITRIC OXIDE; OXYGEN; TETROFOSMIN TC 99M;

BLOOD VESSEL OCCLUSION; CARDIOVASCULAR DISEASE; CHELATION THERAPY; CLINICAL FEATURE; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FOLLOW UP; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART OUTPUT; HEART SCINTISCANNING; HEART VENTRICLE OVERLOAD; HEMOLYSIS; HUMAN; LABORATORY TEST; LUNG FUNCTION; MEDICAL LITERATURE; MYOCARDIAL DISEASE; OXYGEN CONSUMPTION; OXYGEN DISSOCIATION CURVE; OXYGEN TRANSPORT; PATHOPHYSIOLOGY; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; SICKLE CELL ANEMIA; SYMPTOM; VASCULAR ENDOTHELIUM;

ANEMIA, SICKLE CELL; CARDIAC OUTPUT; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMORBIDITY; ELECTROCARDIOGRAPHY; FEMALE; GREECE; HEART FUNCTION TESTS; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 28944451068     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: 10.2143/AC.60.6.2004929     Document Type: Review

References (87)

1. Herrick JB. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anaemia. Arch Intern Med 1910; 6: 517-21.
2. Klinefelter H. The heart in sickle cell anemia. Am J Med Sci 1942; 203: 34-51.
3. Oliveira E, Gomez-Patino N. Falcemic cardiomyopathy. Report of a case. Am J Cardiol 1963; 11: 686-8.
4. Varat MA, Adolph RJ, Fowler NO. Cardiovascular effects of anemia. Am Heart J 1972; 83: 415-26.
5. Bromberg PA, Jensen WN, Mc Donough M. Blood oxygen dissociation curves in sickle cell disease. J Clin Lab Med 1967; 70: 480-8.
6. Groves BM, Brondage BH, Elliott CG. Pulmonary hypertension associated with hepatic cirrhosis. In Fishman AP, ed. The pulmonary circulation: normal and abnormal. University of Pennsylvania Press, Philadelphia, 1990: 359-69.
7. Lindsay J, Meshel J, Patterson R. The cardiovascular manifestations of sickle cell disease. Arch Intern Med 1974; 133: 643-51.
8. Faller DV. Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol 1999; 26(1): 74-84.
9. Solovey A, Lin Y, Browne P, Choon S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 1997; 337: 1584-90.
10. Setty BNY, Chen D, Stuart MJ. Sickle cell vaso-occlusive crisis is associated with abnormalities in the ratio of vaso-constrictor to vasodilator propeptides. Pediatr Res 1995; 38: 95-102.
11. Winsor T, Burch GE. The electrocardiogram and cardiac state in active sickle cell anemia. Am Heart J 1945; 29: 685-96.
12. Uzsoy NK. Cardiovascular findings in patients with sickle cell anemia. Am J Cardiol 1964; 13: 320-8.
13. Baroldi G. High resistance of the human myocardium to shock and red blood cell aggregation (sludge). Cardiology 1969; 54: 271-7.
14. Gerry J, Buckley B, Hutchins G. Clinicopathologic analysis of cardiac dysfunction in 52 patients with sickle cell anemia. Am J Cardiol 1978; 42: 211-6.
15. Martin CR, Johnson CS, Cobb C, Tatter D, Haywood LJ. Myocardial infarction in sickle cell disease. J Nat Med Assoc 1996; 88(7): 428-32.
16. Tap, San M, Mete UO, Kaya M. Ultrastructural alterations in the myocardium of patients with sickle cell anemia. J Submicrosc Cytol Pathol 2001; 33(1-2): 151-6.
17. Rubier S, Fleischer RA. Sickle cell states and,cardiomyopathy: sudden death due to pulmonary thrombosis and infarction. Am J Cardiol 1967; 19: 867-73.
18. Karayalcin G, Rosner F, Kim KY, Chandra P, Aballi AJ. Sickle cell anemia - clinical manifestations in 100 patients and review of the literature. Am J Med Sci 1975; 269: 51-68.
19. Martin C, Cobb C, Tatter D, Johnson C, Haywood LJ. Acute myocardial infarction in sickle cell anemia. Arch Intern Med 1983; 143: 830-1.
20. Barrett O Jr, Saunders DE Jr, McFarland DE, Humphries JO. Myocardial infarction in sickle cell anemia. Am J Hematol 1984; 16(2): 139-47.
21. McCormick WF. Massive nonatherosclerotic myocardial infarction in sickle cell anemia. Am J Forensic Med Pathol 1988; 9: 151-4.
22. Hurst JW The Heart. McGraw-Hill, New York, 1974, p. 1362.
23. Yater WN, Hansmann GH. Sickle cell anemia: a new cause of cor pulmonale. Am J Med Sci 1936; 191: 474-84.
24. Powars D,Weidman J, Odom-Maryon T, Niland J, Johnson C. Sickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure. Medicine 1988; 67(1): 66-76.
25. Adedeji M, Cespedes J, Alien K, Subramony C, Hughson MD. Pulmonary thrombotic arteriopathy in patients with sickle cell disease. Arch Pathol Lab Med 2001; 125(11): 1436-41.
26. Haque AK, Gokhale S, Rampy BA, Adegboyega P, Duarte A, Saldana MJ. Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Hum Pathol 2002; 33(10): 1037-43.
27. Aessopos A, Farmakis D, Loukopoulos D. Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes. Blood 2002; 99(1): 30-5.
28. Aessopos A, Samarkos M, Voskaridou E, Papaioannou D, Tsironi M, Kavouklis E, Vaiopoulos G, Stamatelos G, Loukopoulos D Arterial calcifications in beta-thalassemia. Angiology 1998; 49(2): 137-43.
29. Falk R, Hood W. The heart in sickle cell anemia. Arch Intern Med 1982; 142: 1680-4.
30. Graettinger JS, Parsons RL, Campbell JA. A correlation of clinical and hemodynamic studies in patients with mild and severe anemia with and without congestive failure. Ann Int Med 1963; 58:617-26.
31. Johnson CS, Giorgio AJ. Arterial blood pressure in adults with sickle cell disease. Arch Intern Med 1981; 141(7): 891-3.
32. Rodgers GP, Walker EC, Podgor MJ. Is "relative" hypertension a risk factor for vaso-occlusive complications in sickle cell disease? Am J Med Sci 1993; 305(3): 1506.
33. Foucan L, Salmi LR, Billy-Brissac R, Bourhis V, Bangou J. Arterial pressure and urinary excretion of albumin in adults with sickle cell disease. Presse Med 1995; 24(31): 1428-32.
34. Stark P, Pfeiffer WR. Intrathoracic manifestations of sickle cell disease. Radiology 1985; 25: 33-5.
35. Stevens M, Crooks G, Serjeant G. The development of cardiomegaly in homozygous sickle cell disease. West Indian Med J 1985; 34: 253-6.
36. Holloman K, Johnson C, Haywood J. Electrocardiogram analysis in adult patients with sickle cell disease. J Med Ass 1987; 79(8): 809-14.
37. Lippman SM, Niemann JT, Thigpen T, Ginzton LE, Laks MM. Abnormal Q wave in sickle cell disease. Prevalence and causative factors. Chest 1985; 88(4): 5438.
38. Diggs LW. Anatomical lesions in sickle cell disease. In: Sickle cell disease. Mosby Co, St-Louis, 1973.
39. Saad STO, Arruda VR, Junqueira OOMD, Schelini FA, Coelho OB. Acute myocardial infarction in sickle cell anemia associated with severe hypoxia. Postgrad Med J 1990; 66: 1068-70.
40. Aessopos A, Samarcos M, Hadjinikolaou P, Vaiopoulos G, Skoumas V, Kolainis I, Loukopoulos D. Myocardial infarction with normal coronary arteries in S/beta thalassaemia patients. Eur Heart J 1996; 17: 317-8.
41. Mansi IA, Rosner F. Myocardial infarction in sickle cell disease. J Natl Med Assoc 2002; 94(6): 448-52.
42. Alpert BS, Oilman PA, Strong WB, Ellison MF, Miller MD, McFarlane J, Hayashidera T. Hemodynamic and ECG response to exercise in children with sickle cell anemia. Am J Dis Child 1981; 135: 361-6.
43. Maisel A, Friedman H, Flint L, Koshy M, Prabhu R. Continuous electrocardiogram monitoring in patients with sickle cell anemia during pain crisis. Clin Card 1983; 6: 339-44.
44. Covitz W, Espeland M, Gallagher D, Hellenbrand W, Leff S, Talner N. The heart in sickle cell anemia. The Cooperative Study of Sickle Cell Disease (CSSCD). Chest 1995; 108: 1214-9.
45. Gerry JL, Baird MG, Fortuin NJ. Evaluation of left ventricular function in patients with sickle cell anemia. Am J Med 1976; 60: 968-72.
46. Balfour IC, Covitz W, Davis H, Rao PS, Strong WB, Alpert BS. Cardiac size and function in children with sickle cell anemia. Am Heart J 1984; 108: 345-50.
47. Lester AL, Sodt CP, Hutcheon N, Arcilla AR. Cardiac abnormalities in children with sickle cell anemia. Chest 1990; 98: 1169-74.
48. Martins W, Mesquita ET, Cunha DM, Pinheiro LA, Romeo Filho LJ, Pareto Junior RC. Doppler echocardiographic study in adolescents and young adults with sickle cell anemia. Arq Bras Cardiol 1999; 73(6): 463-74.
49. Denenberg B, Criner G, Jones R, Spann J. Cardiac function in sickle cell anemia. Am J Cardiol 1983; 51: 1674-8.
50. Val-Mejias J, Lee WK, Weisse AB, Ragan TJ. Left ventricular performance during and after sickle cell crisis. Am Heart J 1979; 97(5): 585-91.
51. Lewis JF, Maron BJ, Castro O, Moosa YA. Left ventricular diastolic filling abnormalities identified by Doppler echocardiography in asymptomatic patients with sickle cell anemia. J Am Coll Card 1991; 17(7): 1473-8.
52. Cipolotti R, Costa GB, Lima WH, Franco RP, Mello EV, Dal Fabbro AL, Gurgel RQ, Cuevas LE. Echocardiographic characteristics of patients with sickle cell anaemia in Sergipe, Brazil. J Trop Pediatr 2001; 47(2): 73-6.
53. Batra AS, Acherman RJ, Wong WY, Wood JC, Chan LS, Ramicone E, Ebrahimi M, Wong PC. Cardiac abnormalities in children with sickle cell anemia. Am J Hematol 2002; 70(4): 306-12.
54. Kane A, Mbengue-Dieye A, Dieye O, Sylla A, Sail G, Diouf SM, Kuakuvi N. Echocardiographic aspects in pediatrie patients with sickle cell disease. Arch Pediatr 2001; 8(7): 707-12.
55. Lippman SM, Ginzton LE, Thigpen T, Tanaka KR, Laks MM. Mitral valve prolapse in sickle cell disease. Presumptive evidence for a linked connective tissue disorder. Arch Intern Med 1985; 145(3): 435-8.
56. Lippman SM, Abergel RP, Ginzton LE, Uitto J, Tanaka KR, Miyamoto EK, Laks MM. Mitral valve prolapse in sickle cell disease: manifestation of a generalized connective tissue disorder. Am J Hematol 1985; 19(1): 1-12.
57. Manno B, Burka E, Hakki A, Manno CS, Iskandrian As, Noone AM. Biventricular function in sickle-cell anemia: radionuclide angiographie and thallium-201 scintigraphic evaluation. Am J Cardiol 1983; 52: 584-7.
58. Covitz W, Eubig C, Balfour IC, Jerath R, Alpert BS, Strong WB, DuRant RH. Exercise-induced cardiac dysfunction in sickle-cell anemia. A radionuclide study. Am J Cardiol 1983; 51: 570-5.
59. Norris S, Johnson C, Hayward J. Sickle cell anemia: Does myocardial ischemia occur during crisis? J Natl Med Assoc 1991; 83: 209-13.
60. Aessopos A, Tsironi M, Vassiliadis I, Farmakis D, Fountos A, Voskaridou E, Perakis A, Deftereos S, Loutradi A, Loukopoulos D. Exercise-induced myocardial perfusion abnormalities in sickle b-thalassemia: Tc-99m Tetrofosmin Gated SPECT Imaging study. Am J Med 2001; 111: 355-9.
61. Acar P, Maunoury C, de Montalembert M, Dulac Y. Abnormalities of myocardial perfusion in sickle cell disease in childhood: a study of myocardial scintigraphy. Arch Mal Coeur Vaiss 2003; 96(5): 507-10.
62. Mozzarelli A, Hoftrichter J, Eaton WA. Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo. Science 1987; 237: 500-6.
63. Kokot K, Schaefer RM, Teschner M, Gilge U, Plass R, Heidland A. Activation of leukocytes during prolonged physical exercise. Adv Exp Med Biol 1988; 240: 57-63.
64. Camus G, Pincemail J, Ledent M, Juchmes-Ferir A, Lamy M, Deby-Dupont G, Deby C. Plasma levels of polymorphonuclear elastase and myeloperoxidase after uphill walking and downhill running at similar energy cost. Int J Sports Med 1992; 13: 443-6.
65. Rehman J, Mills PJ, Carter SM, Chou J, Thomas J, Maisel AS. Dynamic exercise leads to an increase in circulating ICAM - 1 : further evidence for adrenergic modulation of cell adhesion. Brain Behav Immun 1997; 11(4): 343-51.
66. Kacimi R, Karliner JS, Koudssi F, Long CS. Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia. Circ Res 1998; 82(5): 576-86.
67. Johnson WH, McCrary RB, Mankad VN Transient left ventricular dysfunction in childhood sickle cell disease. Pediatr Cardiol 1999; 20(3): 221-3.
68. Manci EA, Culberson DE, Yang YM, Gardner TM, Powell R, Haynes J Jr, Shah AK, Mankad VN; Investigators of the Cooperative Study of Sickle Cell Disease. Causes of death in sickle cell disease: an autopsy study. Br J Haematol 2003; 123(2): 359-65.
69. Bertrand E, Renambot J, Chauvet J, Seka R, Ticolat R, Odi Assamoi M, Ndori R, Ekra A. Coronary disease with normal coronarography in the black Africans: epidemiological and clinical data in 31 cases. Role of abnormal hemoglobins. Arch Mal Coeur Vaiss 1993; 86(4): 415-9.
70. Kerle KK, Nishimura KD. Exertional collapse and sudden death associated with sickle cell trait. Mil Med 1996; 161: 766-7.
71. Sutton LL, Castro O, Cross DJ, Spencer JE, Lewis JF. Pulmonary hypertension in sickle cell disease. Am J Cardiol 1994; 74: 626-8.
72. Aboubakr SE, Girgis R, Swerdlow P. Pulmonary hypertension in sickle cell disease (abstract). Am J Respir Crit Care Med 1999; 160: A144.
73. Castro O, Hoque M, Brown B. Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival. Blood 2003; 101(4): 1257-61.
74. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. TV Engl J Med 1994; 330: 1639-44.
75. Vichinsky EP, Styles LA, Colangelo LH, Wright EC, Castro O, Nickerson B. Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease. Blood 1997; 89(5): 1787-92.
76. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minier K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350(9): 886-95.
77. Castro O. Systemic fat embolism and pulmonary hypertension in sickle cell disease. Hematol Oncol Clin North Am 1996; 10: 1289-303.
78. Belcher JD, Marker PH, Weber JP, Hebbel RP, Vercellotti GM. Activated monocytes in sickle cell disease: potential role in the activation of vascular endothelium and vaso-occlusion. Blood 2000; 96: 2451-9.
79. Gutteridge JM, Smith A. Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem J 1988; 256: 861-5.
80. Osarogiagbon UR, Choong S, Belcher JD, Vercellotti GM, Palier MS, Hebbel RP. Reperfusion injury pathophysiology in sickle transgenic mice. Blood 2000; 96: 314-20.
81. Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann N Y Acad Sci 1998; 850: 191-201.
82. Hanley ME, Repine JE. Elastase and oxygen radicals: synergistic interactions. Agents Actions 1993; 42(suppl): 39-47.
83. Collins FS, Orringer EP. Pulmonary hypertension and cor pulmonale in sickle hemoglobinopathies. Am J Med 1982; 73: 814-21.
84. Norris SL, Johnson C, Haywood LJ. Left ventricular filling pressure in sickle cell anemia. J Assoc Acad Minor Phys 1992; 3: 20-3.
85. Simmons BE, Santhanam V, Castaner A, Rao KR, Sachdev N, Cooper R. Sickle cell heart disease. Two-dimensional echo and Doppler ultrasonographic findings in the hearts of adult patients with sickle cell anemia. Arch Intern Med 1988; 148: 1526-8.
86. Gault JH, Covell JW, Braunwald E, Ross JJ. Left ventricular performance following correction of free aortic regurgitation. Ore 1970; 42: 773-80.
87. Engle MA, Evladson M, Smith CH. Late cardiac complications of chronic severe refractory anemia with hemochromatosis. Circ 1964; 30: 698-705.